2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Peripheral Nerve Injuries: new trials by email Literature Review of Peripheral Nerve Injuries trials Research Report on Peripheral Nerve Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
Agnosia (2) · Chronic Pain (2) · Marijuana Abuse (2) · Neuralgia (2) · Pain (2) · Pain, Postoperative (2) · Peripheral Nervous System Diseases (2) · Somatoform Disorders (2)
Chemically-Induced Disorders (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Neuromuscular Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Perceptual Disorders (2) · Postoperative Complications (2) · Signs and Symptoms (2) · Substance-Related Disorders (2) · Trauma, Nervous System (2) · Wounds and Injuries (2)
Apurano Pharmaceuticals GmbH (2)
Germany (2)